These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9793164)

  • 21. [Therapy of acute polyradiculoneuritis (Guillain-Barré syndrome)].
    Hartung HP; Gold R; Zielasek J; Archelos JJ; Toyka KV
    Nervenarzt; 1994 Dec; 65(12):807-18. PubMed ID: 7854501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of Guillain-Barré syndrome by plasma exchange: proposal of a therapeutic strategy].
    Raphael JC; Chevret S; Jars-Guincestre MC; Chastang C; Gajdos P
    Rev Neurol (Paris); 1996 May; 152(5):359-64. PubMed ID: 8881430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Guillain-Barré syndrome and CIDP.
    van Doorn PA
    J Peripher Nerv Syst; 2005 Jun; 10(2):113-27. PubMed ID: 15958124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guillain-Barré syndrome: from the original description to the modern concepts].
    Raphael JC; Sharshar T; Bourdain F; Léger JM
    Ann Med Interne (Paris); 1999 Jan; 150(1):33-41. PubMed ID: 10093660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of Guillain-Barré syndrome].
    Zagar M
    Lijec Vjesn; 1995; 117(9-10):246-9. PubMed ID: 8643018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of Guillain-Barré syndrome.
    Ferner R; Barnett M; Hughes RA
    Br J Hosp Med; 1987 Dec; 38(6):525-8, 530. PubMed ID: 3325121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunoglobulins or plasma exchange? Guillain-Barré syndrome: indications for plasma exchange and immunoglobulins].
    Raphaël JC; Chevret S; Jars-Guincestre MC; Chastang C; Gajdos P
    Ann Med Interne (Paris); 1993; 144(8):526-31. PubMed ID: 8179242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome: a team approach to diagnosis and treatment.
    Dematteis JA
    Am Fam Physician; 1996 Jul; 54(1):197-200. PubMed ID: 8677835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunoglobulin therapy of neuromuscular diseases].
    Schuchardt V
    Nervenarzt; 1993 Feb; 64(2):91-7. PubMed ID: 8450900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange versus intravenous immunoglobulin for Guillain-Barré syndrome.
    Hughes RA
    Ther Apher; 1997 May; 1(2):129-30. PubMed ID: 10225757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of Guillain-Barré syndrome (GBS).
    Hahn AF
    Baillieres Clin Neurol; 1996 Oct; 5(3):627-44. PubMed ID: 9117079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood acute and chronic immune-mediated polyradiculoneuropathies.
    Rabie M; Nevo Y
    Eur J Paediatr Neurol; 2009 May; 13(3):209-18. PubMed ID: 18585069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based review of therapeutic plasma exchange in neurological disorders.
    Chhibber V; Weinstein R
    Semin Dial; 2012; 25(2):132-9. PubMed ID: 22277020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preventive and therapeutic use of intravenous administration of immunoglobulins in intensive care patients in pediatrics].
    Leititis JU
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():29-34. PubMed ID: 8499748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment dilemmas in Guillain-Barré syndrome.
    Verboon C; van Doorn PA; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):346-352. PubMed ID: 27837102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
    Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
    No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison between IVIg and plasma exchange in Guillain-Barré syndrome: a review and decision analysis of the two treatment modalities.
    Dawson WB; Phillips LH
    Clin Neuropharmacol; 1995 Oct; 18(5):377-90. PubMed ID: 8665552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guillain-Barré syndrome. Clinical manifestations and directions for treatment.
    Rees J
    Drugs; 1995 Jun; 49(6):912-20. PubMed ID: 7641605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.